行情

XXII

XXII

22Nd Century
NASDAQ

实时行情|Nasdaq Last Sale

1.790
+0.030
+1.70%
盘后: 1.780 -0.01 -0.56% 16:02 05/20 EDT
开盘
1.810
昨收
1.760
最高
1.820
最低
1.700
成交量
83.73万
成交额
0
52周最高
5.25
52周最低
1.420
市值
2.95亿
市盈率(TTM)
-7.9414
分时
5日
1月
3月
1年
5年
暂无数据
暂无数据
了解XXII最新的财务预测,通过XXII每股收益,每股净资产,每股现金流等数据分析22Nd Century近期的经营情况,然后做出明智的投资选择。
分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

0.00%强力推荐
100.00%买入
0.00%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测XXII价格均价为6.50,最高价位8.50,最低价为5.00。
最高8.50
均价6.50
最低5.00
现价1.790
EPS
实际EPS
预期EPS
-0.07-0.05-0.04-0.02
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
机构持股
总机构数: 166
机构持股: 4,791.70万
持股比例: 29.12%
总股本: 1.65亿
类型机构数股数
增持
30
127.04万
建仓
14
118.95万
减持
40
284.14万
平仓
16
26.38万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
烟草
+0.40%
食品和烟类
+0.67%
高管信息
Non-Executive Chairman/Independent Director
Nora Sullivan
President/Chief Operating Officer
Michael Zercher
Chief Executive Officer/Director
James Mish
Chief Financial Officer
Richard Fitzgerald
Chief Administrative Officer
John Franzino
Vice President
John Brodfuehrer
Vice President - Research & Development
Juan Tamburrino
Director of Investor Relations/IR Contact Officer
Mei Kuo
Independent Director
Clifford Fleet
Independent Director
Anthony Johnson
Independent Director
Michael Koganov
Independent Director
Roger O'Brien
Independent Director
Richard Sanders
暂无数据
暂无数据
XXII 简况
22nd Century Group, Inc. is a biotechnology company. The Company is developing plant-based solutions for the life science, consumer product and pharmaceutical markets. It is focused on the technology that modulate the level of nicotine and other nicotinic alkaloids in tobacco plants and the levels of cannabinoids and terpenes in hemp/cannabis plants through genetic engineering and modern plant breeding techniques. In tobacco, it has developed very low nicotine content (VLNC) tobaccos that grow with approximately 95% less nicotine than tobacco used in conventional cigarettes. It has developed SPECTRUM, is a variable nicotine research cigarette through various independent researchers. It has developed a VLN 2.0 prototype cigarette through its non- genetically modified (GMO) technology. In hemp/cannabis, it is developing hemp/cannabis varieties with increased levels of certain cannabinoids and other agronomic traits.

微牛提供22nd Century Group Inc(NASDAQ-XXII)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的XXII股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易XXII股票基本功能。